ImmunoGen, Inc.

ROYAL BANK OF CANADA

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

77,312

Value ($000)

2,292

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,292	0.0%	77,312	12/31/2023
2023 Q3	11/14/2023	687	0.0%	43,341	9/30/2023
2023 Q2	8/14/2023	413	0.0%	21,891	6/30/2023
2023 Q1	5/15/2023	242	0.0%	62,932	3/31/2023
2022 Q4	2/14/2023	560	0.0%	113,008	12/31/2022
2022 Q3	11/14/2022	563	0.0%	117,730	9/30/2022
2022 Q2	8/15/2022	457	0.0%	101,605	6/30/2022
2022 Q1	5/16/2022	593	0.0%	124,570	3/31/2022
2021 Q4	2/14/2022	1,159	0.0%	156,201	12/31/2021
2021 Q3	11/15/2021	794	0.0%	139,787	9/30/2021
2021 Q2	8/16/2021	874	0.0%	132,749	6/30/2021
2021 Q1	7/20/2021	1,452	0.0%	179,161	3/31/2021
2020 Q4	2/16/2021	1,156	0.0%	179,104	12/31/2020
2020 Q3	11/16/2020	824	0.0%	229,001	9/30/2020
2020 Q2	8/14/2020	911	0.0%	198,193	6/30/2020
2020 Q1	6/16/2020	480	0.0%	140,816	3/31/2020
2019 Q4	2/14/2020	717	0.0%	140,484	12/31/2019
2014 Q1	5/15/2014	409	0.0%	27,404	3/31/2014
2013 Q4	2/14/2014	331	0.0%	22,549	12/31/2013